Month: January 2024

“Key players offering medical image analysis software products in this market include GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Inc. (Japan)”

The global Medical Image Analysis Software Market is experiencing a remarkable surge, driven by rapid technological innovations and an increasing demand for precision diagnostics in the healthcare sector. This cutting-edge software is revolutionizing medical imaging, providing healthcare professionals with powerful tools to enhance diagnosis, treatment planning, and patient care.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=846

Medical imaging has become an indispensable component of modern healthcare, enabling accurate and non-invasive visualization of internal structures, aiding in early disease detection and guiding medical interventions. The Medical Image Analysis Software Market is a vital player in this revolution, offering a range of advanced solutions that facilitate efficient analysis, interpretation, and management of medical images.

Key Highlights of the Medical Image Analysis Software Market:

AI and Deep Learning Integration: Artificial Intelligence (AI) and deep learning technologies are reshaping the landscape of medical image analysis.

Multi-Modality Analysis: Medical image analysis software is now capable of handling diverse imaging modalities, such as MRI, CT, X-ray, ultrasound, and more.

Quantitative Analysis: The market offers tools for quantitative analysis, enabling precise measurements and quantification of disease progression.

Virtual Reality (VR) and Augmented Reality (AR): VR and AR technologies are being integrated into medical image analysis software, allowing clinicians to visualize and interact with medical images in three-dimensional space.

Cloud-Based Solutions: Cloud-based medical image analysis solutions offer remote accessibility, seamless collaboration, and cost-effective storage.

Global Market Expansion: The Medical Image Analysis Software Market is witnessing significant growth across regions, driven by the rising prevalence of chronic diseases, an aging population, and the increasing adoption of advanced healthcare technologies.

Strategic Collaborations: Industry players are forming strategic partnerships with research institutions and healthcare providers to develop innovative solutions, fostering a collaborative ecosystem for driving further advancements in medical image analysis.

As the Medical Image Analysis Software Market continues to evolve, it is anticipated to play a pivotal role in shaping the future of healthcare. The integration of AI, multi-modality analysis, quantitative assessment, and emerging technologies like VR and AR is set to redefine medical imaging, enabling healthcare professionals to deliver more precise and personalized patient care.

Browse Complete Report @ https://www.marketsandmarkets.com/Market-Reports/medical-image-analysis-software-market-846.html

Key Market Players

Key players in the medical image analysis software market include GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Inc. (Japan), Agfa HealthCare (Belgium), International Business Machines Corporation (US), Carestream Health, Inc. (US), AQUILAB SAS (France), Esaote S.p.A. (Italy), MIM Software, Inc. (US), Image Analysis, Ltd. (UK), ScienceSoft USA Corporation (US), Xinapse Systems Ltd. (UK), INFINITT Healthcare Co., Ltd. (South Korea), Dentsply Sirona (US), Medis Medical Imaging Systems BV (Netherlands), Neusoft Medical Systems Co., Ltd. (China), Planmeca Oy (Finland), AnalyzeDirect, Inc. (US), Arterys, Inc. (US), and Media Cybernetics (US). Other players in the market include QMENTA (US), Cefla Medical Equipment (Italy), Ziosoft (US), Kitware, Inc. (US), and Lunit Inc. (South Korea).

GE Healthcare (US) held the leading position in the global medical image analysis software market. The company offers an extensive range of medical image analysis software. To further strengthen its product portfolio and market presence, the company focuses on new product developments, expansions, and collaborations as key growth strategies.

North America to occupy the largest share of the medical image analysis software market

North America accounted for the largest share of the medical image analysis software market. Favorable government initiatives to support the adoption of healthcare IT, and the presence of key market players are favorable factors for market growth in this region.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=846

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/medical-image-analysis-software-market-846.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Medical Image Analysis Software Market Size, Share, Growth Analysis, and Forecast 2027

“The European market is the second-largest antibody therapeutics market globally. One of the major factors supporting the high growth of the European antibody therapeutics market is the advancements in antibody therapy research in the region. Major countries contributing to this growth include Germany, the UK and France.”

Antibody Therapeutics Market in terms of revenue was estimated to be worth $247.3 billion in 2023 and is poised to reach $479.0 billion by 2028, growing at a CAGR of 14.1% from 2023 to 2028 according to a new report by MarketsandMarkets. The growing advancements in antibody engineering, the growing demand for oncology antibody therapeutics and the increasing clinical pipeline focus on antibody therapeutics are the factors supporting the growth of this market. 

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=178852478 

Browse in-depth TOC on “Antibody Therapeutics Market”

313 – Tables

51 – Figures

306 – Pages

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the antibody therapeutics market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=178852478

Key Market Players of Antibody Therapeutics Industry:

The market for antibody therapeutics market is consolidated, with key players strategizing to capture the market. Prominent players in the antibody therapeutics market are F. Hoffmann-La Roche Ltd. (Switzerland), AbbVie Inc. (US), Johnson & Johnson (US), Merck KGaA (Germany), Bristol-Myers Squibb (US), AstraZeneca (UK), Sanofi (France), Regeneron Pharmaceuticals, Inc. (US), Novartis AG (Switzerland), Amgen, Inc. (US), Biogen Inc. (US) among others.

Antibody Therapeutics Market Dynamics:

Drivers:

1.  Growing advancements in antibody engineering

Restraints:

1.  Stringent regulatory approval process

Opportunities:

1.  Increasing collaboration of pharmaceutical companies with CROs, CDMOs and academic institutions

Challenge:

1. Complexities in manufacturing processes

All the market segments have been divided for the Antibody Therapeutics market to forecast revenue and analyze trends in each of the following submarkets:

By Format

• Monoclonal antibody
• Polyclonal antibody therapy
• Bispecific antibody
• Antibody fragment
• Other antibody formats

By Disease Areas

• Autoimmune & inflammatory diseases
• Oncology
• Hematology
• Infectious diseases
• Osteology
• Immunology
• Neurology
• Other disease areas

By Route of Administration

• Intravenous
• Subcutaneous
• Other routes of administration

By Source

• Human
• Humanized
• Chimeric
• Other sources

By End User

• Hospitals
• Long-term care facilities
• Other end users

By Region

• North America
• Europe
• Asia Pacific (APAC)
• Latin America
• Middle East

Recent Developments of Antibody Therapeutics Industry

• In October 2023, F. Hoffmann-La Roche Ltd. entered into a definitive agreement to acquire Televant. Through this agreement, Roche received the development, manufacturing and commercialization rights in the US and Japan for Telavant’s RVT-3101, a novel TL1A directed antibody.
• In January 2023, AbbVie Inc. and Immunome, Inc. entered into strategic collaboration to identify up to 10 novel target-antibody pairs leveraging Immunome’s Discovery Engine.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=178852478

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/antibody-therapeutics-market-178852478.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Antibody Therapeutics Market Analysis, Insight, Challenges, Overview & Scope for Expand to Latest Development

“North America accounted for the largest share of the radiation dose management market. The region’s leadership can be attributed to its significant healthcare IT expenditure, stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, and the presence of stringent regulatory requirements regarding patient safety.”

Radiation Dose Management Market in terms of revenue was estimated to be worth $343 million in 2023 and is poised to reach $654 million by 2028, growing at a CAGR of 13.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth in the radiation dose management market is primarily driven by a surge in the utilization of medical imaging modalities, propelled by a rising incidence of chronic diseases. As healthcare demands increase, the prevalence of diagnostic and interventional procedures involving ionizing radiation, such as X-rays and CT scans, is on the rise. Additionally, there is a growing awareness regarding radiation dose management practices among healthcare professionals and patients, further emphasizing the need for comprehensive solutions. The convergence of these factors, including the use of medical imaging, increasing awareness of radiation risks, increasing prevalence of chronic diseases, and the growth in radiology equipment installations, collectively contribute to the growth of the radiation dose management market in the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82326344

Browse in-depth TOC on “Radiation Dose Management Market”

286 – Tables

35 – Figures

300 – Pages

Standalone solutions accounted for the larger share of the radiation dose management solution market in 2022

On the basis of product & service, the radiation dose management market is segmented into radiation dose management solutions and services. The radiation dose management solution is further sub-segmented into standalone and integrated. In 2022, the standalone solution segment held the largest share in the market. Due to stringent regulations and standards governing radiation exposure in healthcare, there is an increasing emphasis on compliance. As standalone and integrated solutions offer features that enable healthcare providers to adhere to regulatory requirements efficiently. The emphasis on enhancing overall patient outcomes serves as a driving force for the widespread adoption of radiation dose management solutions.

By application, the oncology segment accounted for the largest market share in 2022

Based on application, the radiation dose management market is segmented into oncology, cardiology, orthopaedic applications, dental, and other application. The oncology segment accounted for the largest market share in 2019. The rising prevalence of cancer, are driving the demand for oncology treatments, including radiation therapy. There is growing emphasis on personalized medicine in oncology, as treatments are tailored to individual patients based on their unique characteristics and the specific nature of the cancer. This personalized approach necessitates precise and individualized radiation dose planning and management, driving the demand for advanced solutions within the oncology segment.

Hospitals are the largest end users of the radiation dose management market

Based on end users, the radiation dose management market is segmented into hospitals and healthcare system, ambulatory surgery centres, diagnostic and imaging centres, and other end users. The hospitals segment accounted for the largest market share in 2022. Hospitals conduct a substantial number of medical imaging procedures, such as X-rays, CT scans, and fluoroscopy, for diagnostic purposes. The increased frequency of these procedures contributes to a greater need for radiation dose management to ensure patient safety and regulatory compliance. Moreover, the rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities are the major factors responsible for the high demand for radiation dose management solutions in hospitals.

North America dominates the global radiation dose management market

The radiation dose management market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2022, North America accounted for the largest share of the radiation dose management market. The region’s leadership can be attributed to its significant healthcare IT expenditure, stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, and the presence of stringent regulatory requirements regarding patient safety.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82326344

Radiation Dose Management Market Dynamics:

Drivers:

1. Growing concerns over radiation exposure

Opportunities:

1. Growing focus on oncology and nuclear medicine

Challenge:

1. Lack of benchmarking for dose optimization across the globe

Key Market Players of Radiation Dose Management Industry:

Prominent players in the radiation dose management market include Bayer AG (Germany), GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), FUJIFILM Holdings Corporation (Japan), Canon Inc. (Japan), PACSHealth, LLC (US), Sectra AB (Sweden), Bracco Imaging S.p.A. (Italy), Qaelum N.V. (Belgium), Agfa Healthcare (Belgium), Novarad Corporation (US), Medic Vision (US), Volpara Solutions Inc. (US), Guerbet (France), Medsquare (France), and INFINITT Healthcare Co. Ltd. (South Korea).

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (35%), Europe (24%), Asia Pacific (25%), Latin America and Middle East Africa (16%)

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=82326344

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/radiation-dose-management-market-82326344.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Radiation Dose Management Market Worth $654 Million | MarketsandMarkets™

“China accounted for the largest share of the Asian cystatin C assay market. The large share of China can be attributed to the government efforts to increase awareness about the early detection of diseases and regular health check-ups; rising healthcare expenditure; the increasing number of hospitals and clinical diagnostic laboratories in India and China; and strengthening research base for diagnostic procedures across India, China, and Japan, rising cases of CKD.”

Cystatin C Assay Market in terms of revenue was estimated to be worth $377 million in 2023 and is poised to reach $540 million by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by growing number of old age population and rising number of kidney diseases. However, high development costs of cystatin C assay may challenge the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186075328

The Cystitis C test industry is balanced for critical development within the close future, driven by a rising request for exact and dependable biomarkers in healthcare. Cystitis C, a promising marker of kidney work, is picking up noticeable quality as an elective to conventional creatinine-based estimations. With a maturing populace, the expanding predominance of incessant kidney infections, and a developing accentuation on early illness discovery, the Cystitis C measure industry is anticipated to grow quickly.

Browse in-depth TOC on “Cystatin C Assay Market”

215 – Tables

42 – Figures

271 – Pages

Key Market Players of Cystatin C Assay Industry:

The significant players in the cystatin C assay are Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific Inc. (US), Abbott (US), Roche Diagnostics Limited. (Switzerland), and Bio-Techne (US), Randox Laboratories Ltd. (UK), DiaSys Diagnostic Systems GmbH (Germany), and Eurolyser Diagnostica GmbH (Austria)

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186075328

Cystatin C Assay Market Dynamics:

Drivers:

• Rising prevalence of kidney diseases
• Growing geriatric population
• Recent advancements in chemiluminescence immunoassay technologies
• Growth in biotechnology and biopharmaceutical industries
• Increasing adoption of POC testing
• Supportive government policies

Restraints:

• Stringent requirements for approval of cystatin C assay instruments and consumables
• High development costs of cystatin C assays

Opportunities:

• Growth opportunities in emerging economies
• Importance of companion diagnostics
• Development of condition-specific biomarkers and tests

Challenge:

• Dearth of skilled professionals

Segmentation by product and service

• Analyzers
• Kits
• Reagents

Segmentation by application

• Diagnostics
• Research

Segmentation by end user

• Hospitals
• Clinical Laboratories
• Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes

Regional segmentation

• North America holds largest share
• Asia Pacific fastest growing region
• Europe second largest segment
• Latin America and Middle East & Africa emerging markets

Regional market breakdown

• North America largest share due to high healthcare spending, developed infrastructure
• Asia Pacific fastest growth from increasing healthcare access and aging populations
• Europe also major market but growing at slower pace than APAC
• Latin America and Middle East & Africa smaller markets but seeing growth

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=186075328

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cystatin-c-assay-market-186075328.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cystatin C Assay Market Trends, Scope, growth, Size, Technology, & Customization Available for Forecast 2028

“The key players in the robotic dentistry market include Planmeca Oy (Finland), Align Technology Inc. (US), Intuitive Surgical Inc (US), DENTSPLY SIRONA Inc. (US), and Envista Holdings Inc. (US). These companies adopted strategies such as partnerships, acquisitions, and investments to strengthen their presence in the robotic dentistry market.”

Robotic Dentistry Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $1.0 billion by 2028, growing at a CAGR of 17.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Developing countries such as China, India, the Middle East, and other APAC and Latin American countries present a lucrative opportunity for players in the market. This is mostly due to their expanding middle-class population, increasing disposable incomes, and the rising demand for dental tourism. 

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48850788 

Browse in-depth TOC on “Robotic Dentistry Market” 

150 – Tables

100 – Figures

200 – Pages 

Key Market Players of Robotic Dentistry Industry: 

The key players in the robotic dentistry market include Planmeca Oy (Finland), Align Technology Inc. (US), Intuitive Surgical Inc (US), DENTSPLY SIRONA Inc. (US), and Envista Holdings Inc. (US). These companies adopted strategies such as partnerships, acquisitions, and investments to strengthen their presence in the robotic dentistry market. 

During the forecast period, Asia Pacific is expected to be the fastest growing region in the robotic dentistry market. “ 

The robotic dentistry is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa. Asia Pacific is expected to be the fastest-growing region in the robotic dentistry market during the forecast period. Growth in Asia Pacific in the robotic dentistry market is driven by the growing geriatric population, growing dental tourism, and factors such as the increasing number of dental professionals, the rising incidence of dental diseases, and the growing number of implant procedures. 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=48850788

Robotic Dentistry Market Dynamics:

Drivers:

• Technological advancements in robotic dentistry

Restraints:

• High cost of robotic dentistry and dental procedures

Opportunities:

• Potential for growth in emerging countries

Challenges:

• Dearth of trained dental practitioners

The study categorizes the robotic dentistry market to forecast revenue and analyze trends in each of the following submarkets:

By Product & service

• Standalone robot
• Robot-assisted system and software
• Services

By Applications

• Implantology
• Endodontics
• Others

By End User

• Dental Hospitals and Clinics
• Dental Academic and research institutes

By Region

• North America
• Europe
• Asia Pacific
• South Korea
• Latin America
• Middle East and Africa

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=48850788

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/robotic-dentistry-market-48850788.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Precision in Progress: Unveiling the Growth Trajectory of the Robotic Dentistry Market at a 17.3% CAGR through 2028

“North America has emerged as the fastest growing region from 2023 to 2028. The collective revenue share of Europe, across both RNA vaccines and RNA drugs is highest in 2022, and this is set to continue through the forecast period.”

RNA Therapeutics Market in terms of revenue was estimated to be worth $13.7 billion in 2023 and is poised to reach $18.0 billion by 2028, growing at a CAGR of 5.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in this market is largely driven by factors such as the increasing number of partnerships and collaborations among market players and RNA technology manufacturers, expanding modalities for RNA therapeutics, and the rising number of emergency use authorizations and approvals for COVID-19 booster vaccines. The emergence of small activating RNAs (saRNAs) and circular RNAs (circRNAs) has expanded the scope of RNA therapeutics. saRNAs are 21-nucleotide long double-stranded RNAs (dsRNAs) complementary to the promoter region of a targeted gene. They can upregulate gene expression, potentially correcting deficiencies associated with genetic disorders and re-activating tumor suppressor genes in multiple types of cancers. On the other hand, the discontinuation/recalls of RNA therapeutic products is expected to hinder market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235963408

Browse in-depth TOC on “RNA Therapeutics Market”

135 – Tables

36 – Figures

171 – Pages

Key Market Players Of RNA Therapeutics Industry :

The prominent players in the global RNA therapeutics market include Moderna, Inc. (US), Alnylam Pharmaceuticals, Inc. (US), Pfizer Inc. (US), Novartis AG (Switzerland), Ionis Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US), Sanofi (France), Arrowhead Pharmaceuticals, Inc. (US), BioNtech SE (Germany), Orna Therapeutics (US), CRISPR Therapeutics (Switzerland), Silence Therapeutics (UK), Astellas Pharma Inc. (Japan), CureVac SE (Germany), Sirnaomics (US), Arcturus Therapeutics Inc. (US) and Arbutus Biopharma (US).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235963408

RNA Therapeutics Market Dynamics:

Drivers:

1.  Increasing partnerships and collaborations among market players and RNA technology manufacturers

Restraints:

1.  Discontinuation or recalls of RNA therapeutic products

Opportunities:

1.  Higher progress in the development of RNA aptamer-based therapeutics

Challenge:

1. Rapid degradation by ubiquitous RNases in environment and tissues with strong immunogenicity of exogenous RNA

This research report categorizes the RNA therapeutics market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Vaccines
• Drugs

By Type

• mRNA Therapeutics
• RNA Interference (RNAi) Therapeutics
• Antisense Oligonucleotide (ASO) Therapeutics
• Other Therapeutics

By Indication

• Infectious Diseases
• Rare Genetic Diseases/Hereditary Diseases
• Other Indications

By End User

• Hospitals and Clinics
• Research Settings

By Region

• North America
• Europe
• Asia Pacific
• South Korea
• Rest of the World

Recent Developments of RNA Therapeutics Industry

• In February 2023, Moderna, Inc. received authorization from Health Canada for its COVID-19 booster vaccine, mRNA-1273.214 (SpikevaxBivalent Original/Omicron). This vaccine is designed for immunization against COVID-19 in children and adolescents between 6 to 17 years.
• In January 2023, the US FDA granted Breakthrough Therapy Designation for Moderna’s investigational mRNA vaccine candidate—mRNA-1345. This vaccine was developed to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) in adults aged 60 years or older.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=235963408

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/rna-therapeutics-market-235963408.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: RNA Therapeutics Market Projected to Reach $18.0 billion, Share, Growth Strategies and Segment Outlook till 2028

“Browse 196 market data Tables and 53 Figures spread through 280 Pages and in-depth TOC on “Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028”

The molecular quality controls industry is set to witness significant growth and advancements in the near future. With the increasing demand for accurate and reliable molecular diagnostic tests, the need for robust quality control solutions becomes paramount. Molecular quality controls provide essential tools to ensure the accuracy, precision, and reliability of laboratory testing procedures, including nucleic acid amplification, sequencing, and other molecular assays. As technology continues to advance, the industry is expected to witness the development of more sophisticated and comprehensive quality control materials that mimic complex clinical samples, allowing for better evaluation of assay performance. Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms will enable the generation of data-driven quality control strategies, optimizing test accuracy and efficiency. As the molecular diagnostics field expands and becomes more integrated into routine clinical practice, the molecular quality controls industry will play a pivotal role in ensuring the quality and integrity of test results, ultimately contributing to improved patient care and outcomes.

Molecular Quality Controls Market in terms of revenue was estimated to be worth $0.2 billion in 2023 and is poised to reach $0.3 billion by 2028, growing at a CAGR of 6.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is primarily driven by growing adoption of third-party quality controls, the increasing number of accredited clinical laboratories, increasing government funding for genomic projects, and increasing prevalence of infectious diseases, cancer, and genetic diseases. However, the additional costs involved in the quality control process and budget constraints in hospitals and laboratories, are the major factors that are expected to restrain the growth of this market during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82625523

Browse in-depth TOC on “Molecular Quality Controls Market”

196 – Tables

53 – Figures

280 – Pages

The independent controls segment has accounted for the largest share of the market during the forecast period

Based on product, the molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment accounted for the largest share  of the global molecular quality controls market in 2022. The large share of this segment is attributed to the increasing use of third-party independent quality controls due to their benefits, such as applications across different reagent lots, which helps reduce the cost of operation.

The single-analyte controls has accounted for the largest share of the market during the forecast period.

On the basis of analyte type, the molecular quality controls market is segmented into single-analyte controls and multi-analyte controls. Single-analyte controls accounted for the largest share of the molecular quality controls market in 2022. The large share of this segment can be attributed to the significant use of singleplex assays in hospitals and the low risk of cross-reactivity.

The infectious disease diagnostic segment accounted for the largest share of the market in 2022

Based on application, the molecular quality controls market is segmented into infectious disease diagnostics, oncology testing, genetic testing, and other applications (including cardiovascular disease testing, neurology disease testing, DNA fingerprinting, tissue typing, and microbiology). The infectious disease diagnostics segment accounted for the largest share of the global molecular quality controls market in 2022. The large share of this segment is attributed to the development of advanced assays for different infectious diseases and a significant increase in the prevalence of infectious diseases.

The diagnostic laboratories segment accounted for the largest share of the market in 2022

Based on end users, the molecular quality controls market is segmented into diagnostic laboratories, hospitals, IVD manufacturers & CROs, academic & research institutes, and other end users (blood banks, local public health laboratories, home health agencies, and nursing homes). The diagnostic laboratories segment accounted for the largest share of the molecular quality controls market in 2022. This can be attributed to the increasing number of accredited diagnostic laboratories worldwide and the growing number of laboratory tests performed in diagnostic laboratories.

Asia-Pacific is to witness the highest growth during the forecast period.

The Asia-pacific Molecular Quality Controls market is expected to grow at the highest CAGR during the forecast period of 2023-2028. The high growth rate of this market can be attributed to large patient population in the region, rising healthcare needs, increasing focus on improving the quality of laboratory testing, strategic developments by leading players, and the rapid growth in the number of accredited laboratories.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82625523

Molecular Quality Controls Market Dynamics:

Drivers:

1. Rising number of accredited clinical laboratories
2. Growing adoption of third-party quality controls
3. Increasing investments in genomics
4. Growing preference for personalized medicine
5. Increasing prevalence of infectious diseases and cancer
6. Rising demand for external quality assessment support

Restraints:

1. Budgetary constraints in clinical laboratories
2. Unfavorable reimbursements for molecular tests

Opportunities:

1. Rising demand for multi-analyte controls
2. Growth opportunities in emerging markets

Challenges:

1. Stringent regulatory requirements for IVD products

Key Market Players:

The prominent players in this market are Abbott Laboratories (US), Anchor Molecular (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US),  Bio-Rad Laboratories, Inc. (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), Bio-Techne Corporation (US), Microbiologics, Inc. (US), Steck LLC (US), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Helena Laboratories Corporation (US), Microbix Biosystems Inc. (Canada), Molbio Diagnostics Pvt. Ltd. (India), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).

Recent Developments:

• In 2023, Thermo Fisher Scientific (US) acquired The Binding Site Group to expands the company’s existing specialty diagnostics portfolio with the addition of pioneering innovation in diagnostics and monitoring for multiple myeloma.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=82625523

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/molecular-quality-control-market-82625523.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Molecular Quality Controls Market worth $0.3 billion by 2028

“The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the rapid technology development in nanofiber technologies, expanding manufacturing of generics, growing government budget for R&D, and growing biotechnology industries.”

The pharmaceutical filtration industry is expected to grow significantly in the near future due to the increasing demand for accurate and safe treatments, the growing need for drug development, and the need for biosecurity. The industry is expected to benefit from advances in technology, such as the development of new materials, enabling the development of new, more efficient filtration systems. The industry is also expected to benefit from the increasing demand for biopharmaceuticals, as these drugs require more advanced filtration systems. Furthermore, the increasing need for reducing the cost of drug production is expected to drive the growth of the pharmaceutical filtration market.

Pharmaceutical Filtration Market in terms of revenue was estimated to be worth $13.5 billion in 2023 and is poised to reach $26.2 billion by 2028, growing at a CAGR of 14.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. The pharmaceutical filtration market is expected to grow at a CAGR of 14.2% during the forecast period. Growth in the pharmaceutical filtration market can be attributed to factors such as rapid growth in the R&D and manufacturing of biopharmaceuticals, growing adoption of single use filters, new product developments by key market players, growing filtration scrutiny by regulatory bodies, and advanced development in nano fiber technologies. Despite this, issues such as membrane fouling, and large capital investment required to set up new production facilities are expected to hinder market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209343847

Browse in-depth TOC on “Pharmaceutical Filtration Market”

514 – Tables

49 – Figures

454 – Pages

The single use systems segment accounted for the largest share of the systems segment in the pharmaceutical filtration market in 2022.

Based on products, the pharmaceutical filtration market is segmented into filters, systems, and other products. Filters segment accounted for the largest share of the pharmaceutical market; membrane filters are the key revenue contributors to this segment. Membrane filters are microporous plastic films with specific pore size ratings. These filters are used to separate contaminated particles from liquids. They are available in a variety of polymers, pore sizes, diameters, and surface types.

The nanofiltration segment accounted for the smallest share of the process segment in the pharmaceutical filtration market in 2022.

Based on technique, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The nanofiltration techniques accounted for the smallest market share of this market in 2022, and this can be primarily attributed to the limited retention for salts and univalent ions by nanofilters; nanofiltration membranes being comparatively more expensive than reverse osmosis membranes.

The Asia Pacific region is the fastest-growing region of the pharmaceutical filtration market in 2021.

Based on the region, the pharmaceutical filtration market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the rapid technology development in nanofiber technologies, expanding manufacturing of generics, growing government budget for R&D, and growing biotechnology industries.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209343847

Pharmaceutical Filtration Market Dynamics:

Drivers:

1. Growth of biopharmaceutical industry to drive filtration products demand
2. Rising R&D spending in pharmaceutical & biotechnology industries to drive market growth
3. Increasing adoption of single-use technologies
4. New product launches by leading players support market growth
5. Increasing purity requirements in end user segments

Restraints:

1. Issues in membrane fouling to restrict market growth
2. High capital investment for new production facilities to limit entry of small players

Opportunities:

1. Emerging economies offer lucrative growth opportunities
2. Advances in nanofiber technology to drive possibilities of nanofiltration

Challenges:

1.  Increased cost, reduced speed, and yield of filters to restrict market growth
2.  Difficulty in small players and new entrants survival

Key Market Players:

Key players in the drug discovery service Market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), Thermo Fisher Scientific Inc. (US).

Recent Developments:

• In January 2023, Sartorius AG (Germany) and RoosterBio, Inc. (US) signed a collaboration deal to provide purification solutions and establish scalable downstream manufacturing processes for exosome-based therapies. Through this collaboration, Sartorius will provide its scalable filtration equipment, such as SartoflowSmart and Sartoflow Advanced, for the clarification, concentration, and formulation of exosomes.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=209343847

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pharmaceutical Filtration Market worth $26.2 billion by 2028

“North America in HLA typing for transplant market is attributed to the rapid surge in the organ transplantation procedures, strong foothold of players offering transplant diagnostic products (including HLA typing), and rising research collaborations to identify the novel HLA genes and their role in organ transplantation.”

HLA Typing for Transplant Market in terms of revenue was estimated to be worth $0.8 billion in 2023 and is poised to reach $1.1 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as the increasing transplants volume worldwide, rising number of transplant & diagnostic centers, technological advancements, government initiatives to boost HLA typing services, rising public -private investments boost research in HLA genotyping, and increased focus of players to enhance their manufacturing & distribution capabilities across emerging countries are likely to support the growth of HLA typing for transplant market during the forecast period.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742

In the near future, HLA typing is poised to revolutionize the transplant industry. Rapid advancements in genomics and precision medicine will enable transplant professionals to intricately match donor and recipient HLA profiles, significantly reducing the risk of rejection and the need for immunosuppressive drugs. This breakthrough technology will expand the pool of potential donors, improve transplant success rates, and usher in a new era of life-saving organ and tissue transplantation, offering hope to countless patients awaiting these life-changing procedures.

Key Market Players of HLA Typing for Transplant Industry:

Some of the prominent players in the HLA typing for the transplants market are Thermo Fisher Scientific (US) Illumina, Inc. (US), QIAGEN (Germany), CareDx (US),F. Hoffmann-La Roche Ltd. (Switzerland),Bio-Rad Laboratories, Inc. (US), Immucor, Inc. (US),  Luminex Corporation (US), TBG Diagnostics Limited. (Australia) FUJIREBIO (Japan),Omixon Inc. (US), GenDX (Netherlands), BAG Diagnostics GmbH (Germany), Creative Biolabs (US), and PacBio (US).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742

HLA Typing for Transplant Market Dynamics:

Drivers:

• Increasing number of transplant procedures globally

Restraints:

• costs of molecular tests used for HLA typing procedures

Opportunities:

• Technological shift from non-molecular serological assays to gene-based HLA profiling

Challenge:

• Significant gap between organ availability and demand

This research report categorizes the HLA typing for transplant market to forecast revenue and analyze trends in each of the following submarkets:

By Product & Service

• Reagents & Consumables
• Instruments
• Software & Services

By Technology

• Molecular Assay Technologies
• PCR-Based Molecular Assays
• Real-time PCR
• Sequence-specific Primer-PCR
• Sequence-specific Oligonucleotide-PCR
• Other PCR-based Molecular Assays
• Sequencing-based Molecular Assays
• Sanger Sequencing
• Next-generation Sequencing
• Other Sequencing-based Molecular Assays
• Non-molecular Assay Technologies

By Application

• Diagnostic Applications
• Antibody Screening
• Chimerism Monitoring
• Others
• Research Applications

By Transplant Type

• Solid Organ Transplant
• Soft Tissue Transplant

By End User

• Independent Reference Laboratories
• Hospitals & Transplant Centers
• Research Laboratories & Academic Institutes

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle-East Africa

Recent Developments:

• In September 2023, Omixon, Inc. (US) launched its NanoTYPE RUO Multiplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore’s MinION Platform.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=96374742

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: HLA Typing for Transplant Market Size, Product Trends, Key Companies, Revenue Share Analysis Till 2028